Table 1.
Clinical characteristics of 41 patients aged 6 to 16 with autoimmune thyroiditis and the control group.
| Total N |
Females/males | TSH µIU/mL median (range) |
Anti-TPO IU/mL median (range) | Anti-TG IU/mL median (range) |
|
|---|---|---|---|---|---|
| Primary hypothyroidism (without goiter) | 3 | 3/0 | 74.89 (11.57–137.42) | 156.9 (153.13–318.05) | 342.69 (217.01–375.21) |
| Subclinical hypothyroidism (without goiter) | 6 | 4/2 | 5.28 (5.12–7.36) | 239.59 (78.07–569.56) | 379.84 (82.7–482.35) |
| Primary hypothyroidism with diffuse goiter | 5 | 4/1 | 37.45 (15.24–150.01) | 480.27 (206–653.38) | — |
| Subclinical hypothyroidism with diffuse goiter | 21 | 15/6 | 4.98 (4.43–6.28) | 211.57 (72.95–517.32) | 292.19 (136.47–546.24) |
| Primary hypothyroidism with nodular goiter | 1 | 1/0 | 94.78 | 517.32 | — |
| Subclinical hypothyroidism with nodular goiter | 4 | 3/1 | 4.88 (4.67–4.99) | 243.98 (145.22–526.75) | 619.53 (214.15–1024.91) |
| Diffuse goiter with hyperthyroidism | 1 | 1/0 | 0.01 | 238.78 | — |
| Levothyroxine treatment∗ | 37 | 27/10 | 5.46 (4.43–150.01) | 216.35 (72.95–653.38) | 333.42 (82.7–1024.91) |
| All patients | 41 | 31/10 | 5.26 (0.01–150.01) | 236.35 (72.95–653.38) | 333.42 (82.7–1024.91) |
| Control group | 51 | 34/17 | 1.84 (0.53–3.78) | 36.91 (25.02–51.35) | 39.85 (29.76–52.06) |
∗Including all patients from all subgroups which receive levothyroxine treatment.